A replacement box of hydrogel pads were sent to the customer so she could return them to a store for a refund.On (b)(6) 2017, a medela clinician followed up with the customer and she reported that she went to urgent care and received a steroid shot and also went to her doctor and was prescribed diprolene cream.She has not used the pads since the one time on (b)(6) 2017.She indicated that the rash was clearing up, but as of (b)(6) 2017, there was still redness outlining the pads.The product involved in the complaint has not been returned for evaluation/investigation at this time.Reported issues of rash were investigated under in (b)(4), which determined the probable root causes to be (1) customers with glycerin allergies experiencing aggressive immune reactions due to the fact that glycerin is an integral ingredient in the hydrogel pads or (2) pathogens or allergens that come in contact with exposed hydrogel pads which would subsequently be introduced to the user¿s breast.The customer filed a voluntary medwatch report under mw5070852.
|